Table 2.
Keyword clusters for the second stage (2011–2015).
| Cluster ID | Cluster keywords | Representative keywords |
|---|---|---|
| 0 | Association | Nonalcoholic fatty liver disease; cholesterol-lowering drugs; all-cause mortality; non-cardiovascular mortality; coronary artery disease metabolic syndrome; liver disease; coronary artery disease; arterial stiffness; metabolic control |
| 1 | Nonalcoholic fatty liver disease | Nonalcoholic fatty liver disease; metabolic syndrome; alanine aminotransferase; nonalcoholic steatohepatitis; aspartate aminotransferase nonalcoholic fatty liver disease; omega-3 fatty acids; fatty acids; controlled trial; arterial stiffness |
| 2 | Vitamin E | Fatty liver; metabolic syndrome; nonalcoholic steatohepatitis; hepatic steatosis; growth hormone nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; clinical trials; coronary artery disease; obesity fatty liver |
| 3 | Oxidative stress | Nonalcoholic fatty liver disease; metabolic syndrome; lipid metabolism; hepatic metabolic pathways; aerobic capacity nonalcoholic fatty liver disease; insulin resistance; gut microbiota; coronary artery disease; hepatic metabolic pathways |
| 4 | Blood pressure | Metabolic syndrome; nonalcoholic fatty liver disease; hepatic metabolic pathways; antioxidant status; aerobic capacity nonalcoholic fatty liver disease; novo lipogenesis; hepatic metabolic pathways; obstructive sleep; body mass |
| 5 | Children | Nonalcoholic fatty liver disease; carotid intima-media thickness; ventricular hypertrophy; liver cirrhosis; systolic diameter nonalcoholic fatty liver disease; high-density lipoprotein cholesterol; cardiovascular disease risk; nonalcoholic steatohepatitis; arterial stiffness |
| 6 | Genome wide association | NAFLD; genome wide association; TM6SF2 variant; confers susceptibility; PNPLA3 metabolic syndrome; risk factors; carbohydrate; steatosis; saturated fat |
| 7 | Transient elastography | Nonalcoholic fatty liver disease; mitochondrial dysfunction; nonalcoholic steatohepatitis; isobutyl-isonitrile liver scintigraphy; coronary artery disease nonalcoholic fatty liver disease; chronic kidney disease; diabetes mellitus; coronary computed tomography angiography; coronary artery disease |
NAFLD = nonalcoholic fatty liver disease.